Why the study?
Does preexisting antiplatelet treatment increase the risk of intracranial hemorrhage in acute ischemic stroke patients receiving thrombolysis?
Does preexisting antiplatelet treatment increase the risk of intracranial hemorrhage in acute ischemic stroke patients receiving thrombolysis?
Preexisting antiplatelet therapy does not significantly increase the risk of post-thrombolysis intracranial hemorrhage in the general community-treated ischemic stroke population, though risk may be elevated in patients over 81 years old.
No takes yet. Share an insight, caveat, or question.
Does not support withholding thrombolysis for antiplatelet users; leaves open confirmation in randomized trials.
Meurer et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: